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Use of naturally occurring biocompatible polymeric materials has been the focus of
recent research activity in the design of these dosage forms (1, 2). Polymeric hydrogels
are studied for controlled release applications because of their producing drug release
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Polysaccharide mucilage derived from the seeds of Plan-
tago major L. (family Plantaginaceae) was investigated for
use in matrix formulations containing propranolol hydro-
chloride. HPMC K4M and tragacanth were used as stan-
dards for comparison. The hardness, tensile strength,
and friability of tablets increased as the concentration of
mucilage increased, indicating good compactibility of
mucilage powders. The rate of release of propranolol hy-
drochloride from P. major mucilage matrices was mainly
controlled by the drug/mucilage ratio. Formulations
containing P. major mucilage were found to exhibit a re-
lease rate comparable to HPMC containing matrices at a
lower drug/polymer ratio (drug/HPMC 2:1). These re-
sults demonstrated that P. major mucilage is a better re-
lease retardant compared to tragacanth at an equivalent
content. The results of kinetic analysis showed that in F3
(containing 1:2 drug/mucilage) the highest correlation
coefficient was achieved with the zero order model. The
swelling and erosion studies revealed that as the propor-
tion of mucilage in tablets was increased, there was a
corresponding increase in percent swelling and a de-
crease in percent erosion of tablets. The DSC and FT-IR
studies showed that no formation of complex between
the drug and mucilage or changes in crystallinity of the
drug had occurred.
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close to zero-order kinetics (3). Mucilages and gums have been well known since ancient
times for their medicinal use (4). In recent times, increasing attention has been given to
the application of gums of various sources as pharmaceutical excipients. Plant gums and
exudates are getting screened for their use as pharmaceutical adjuvants. Mucilages are
generally carbohydrate polymers obtained from woody and non-woody plant parts such
as bark, seeds, sap, roots, rhizomes, fruits, and leaves. Mucilages are used for their bind-
ing, thickening, stabilizing, humidifying, disintegrating and release controlling proper-
ties in medicines (5–7). Mucilages from natural sources hydrate and swell on contact
with water and have been used for the preparation of single unit dosage forms (8).
Plantago major L. is a perennial plant that belongs to the Plantaginaceae family. The
plant produces a large amount of seeds. Leaves of P. major are used in traditional medicine
for wound healing. Either whole or crushed leaves are used directly on burns, wasp stings
and wounds of all kinds to stop bleeding, keep the wound clean and to enhance the heal-
ing process. Investigations have shown that the leaves contain a pectin type polysaccha-
ride (PMII) and an arabinogalactan that possesses anti-complementary activity (9).
Seeds are located in capsules (8–16 per capsule) and become sticky in humid water
due to the swelling of the polysaccharides present in the seed coat. Seeds contain mono-
saccharides, disaccharides, and trisaccharides. The outer seed coat contains carbohydrate
polymers that swell in contact with water and form mucilage with high viscosity. These
polysaccharides are composed of xylose, arabinose, galactorunic acid, glucuronic acid,
rhamnose, galactose, and glucose (10).
The aim of the present study is to investigate the suitability of Plantago major seed
mucilage for a matrix-forming agent and propranolol hydrochloride has been chosen as
a model drug. As hydroxypropyl methylcellulose (HPMC) is one of the widely used hy-
drophilic polymers in matrix formulations (11), the present study also compares the re-
lease, swelling and erosion data obtained for matrices containing Plantago major seed
mucilage to those of matrices containing HPMC.
EXPERIMENTAL
Materials
Propranolol hydrochloride (Rouz-daru Co., Iran) was received as a free sample. HPMC
K4M (Colorcon, UK), tragacanth, NaOH, KCl, HCl, magnesium stearate (Merck, Germany)
and potassium dihydrogen phosphate (Fluka, Switzerland) were used as supplied.
Swelling factor
To determine the swelling factor, Plantago major seeds (1 g) were put into graduated
stoppered cylinders that were later filled with distilled water at room temperature up to
the 25 mL mark. Except for intermittent agitation, the cylinders were left undisturbed
for 24 h and the volume of swollen seed layer was then recorded by observation of the
water gel boundary. The test was done in triplicate and the results are shown as mean
values (12).
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Extraction of mucilage
Plantago major seed mucilage was extracted according to the Sharma and Koul me-
thod (12). Ten milliliters of 0.1 mol L–1 hydrochloride was heated to boiling in a 100-mL
Corning flask. The flask was removed from the flame and a 1-g test sample of dry seed
was added to it. Heating was resumed and the process of dissolution of the seed husk
was monitored. When all seeds had changed color, the flask was finally removed from
the flame and the solution was filtered through a clean muslin cloth while still hot. In
order to separate residual traces of mucilage, the seeds were washed twice in 5 mL of
hot water and the solution obtained each time was filtered. The combined filtrate, con-
taining dissolved mucilage, was mixed with 60 mL of 95 % ethyl alcohol, stirred and
allowed to stand for 5 h. Finally, the supernatant liquid was decanted and the beaker
containing the precipitate was dried in an oven maintained at 50 °C. The weight of dry
precipitate was taken to represent the total mucilage content (12).
Viscosity determination
Dried and finely powdered Plantago major seed mucilage (2 g) was suspended in 75
mL of distilled water for 24 h. Distilled water was added up to 100 mL to produce a con-
centration of 2 % (m/V). The mixture was homogenized with a mechanical stirrer for 2 h
and its viscosity was determined using a Brookfield viscometer, spindle –LV2 (Brook-
field LV-II, USA) at 20 rpm and 25 °C.
Preparation of matrix tablets
A series of formulations containing a fixed amount of propranolol hydrochloride
(80 mg), and several amounts of Plantago major seed mucilage powder (drug to mucilage
ratios 1:0.5, 1:1, 1:2) or HPMC K4M, tragacanth (drug to polymer ratios 1:0.5, 1:1, 1:2)
were thoroughly blended for 10 min. Magnesium stearate (1 %, m/m) was then added,
followed by further mixing for 2 min. The resultant powder mixture was compressed
into tablets using a single punch tableting machine (Korsch, Germany), with a 10-mm
diameter flat punch. All matrices were stored in a desiccator for at least 3 days to allow
tablet relaxation before use. Compositions of all formulations are listed in Table I.
Evaluation of tablets
Tablet properties (crushing strength, mass variation, and friability) were deter-
mined by the standard procedure (13). The tensile strength (T) of tablets, which is a mea-
sure of the stress necessary to cause diametric fracture of the compact, was determined
from the mean data obtained from the hardness test carried out on tablets (n = 10) using
an Erweka hardness tester (TBH 30MD, Germany). The T values were computed from





where P is the load applied on the tablet that causes diametric fracture of the tablet of di-
ameter, D, and t is tablet thickness. Content uniformity of the drug in tablets was con-
firmed based on the British Pharmacopoeia method (14).
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In vitro release studies
The United State Pharmacopoeia (USP) basket method was used for all in vitro dis-
solution studies. In this method, distilled water containing hydrochloric acid 0.2 mol L–1
(pH 1.2) and phosphate buffer pH 7.4 without enzyme were used as dissolution media.
The dissolution profile of propranolol hydrochloride was determined according to the
USP basket method at 100 rpm, in 900 mL maintained at 37.0 ± 0.5 °C in a dissolution
tester (Caleva 8ST, Germany). The amount of propranolol hydrochloride was 80 mg in
all formulations. The matrices were placed in 900 mL of distilled water containing hy-
drochloric acid (pH 1.2) for 2 h. The samples were withdrawn at predetermined time in-
tervals (0.5, 1, 1.5, and 2 h), filtered and assayed spectrophotometrically at 289 nm using
a UV/Visible spectrophotometer (Varian, Australia). After 2 h, the dissolution medium
pH was changed from 1.2 to 7.4 using phosphate buffer. The samples were withdrawn at
predetermined time intervals (3, 4, 5, 6, 7, and 8 h) and analyzed by the mentioned method.
The mean of four determinations was used to calculate drug release from each of the
formulations.
Drug release kinetics
Various mathematical equations have been proposed for kinetic analysis of drug re-
lease from the evaluated formulations. The zero order rate Eq. 2 describes the systems
where the drug release is independent of its concentration. The first order rate Eq. 3 de-
scribes drug release from systems where the release is concentration dependent. Accord-
ing to the Higuchi model Eq. 4, drug release from the insoluble matrix is directly propor-
tional to the square root of time and is based on Fickian diffusion (15):
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F1 80 40 – – 1.2 121.2
F2 80 80 – – 1.6 161.6
F3 80 160 – – 2.4 242.4
F4 80 – 40 – 1.2 121.2
F5 80 – 80 – 1.6 161.6
F6 80 – 160 – 2.4 242.4
F7 80 – – 40 1.2 121.2
F8 80 – – 80 1.6 161.6
F9 80 – – 160 2.4 242.4
Qt = k0 t (2)
ln Qt = ln Q0 – k1t (3)
Qt = kH t1/2 (4)
where Qt is the amount of drug released at time t, Q0 is the initial amount of drug in the
tablet and k0, k1 and kH are release rate constants for the zero order, first order and Hi-
guchi models, respectively.
In order to define a model that will represent a better fit for the formulations, disso-
lution data can be further analyzed by the Peppas and Korsemayer equation:
Mt / M¥= Kp tn (5)
where Mt corresponds to the amount of drug released at time t, M¥ is the total amount of
drug that must be released at infinite time, Kp is a constant and n is the release exponent
indicating the type of drug release mechanism. The value of n for a cylinder is < 0.45, for
Fickian release > 45 and < 0.8 for non-Fickian release, 0.89 for the case II release and
> 0.89 for the super case II type release (16). Criteria for selecting the most appropriate
model were based on the best goodness of fit and smallest sum of squared residuals.
Matrix swelling studies
Swelling of the matrices can be measured by their ability to absorb water and swell.
The study was carried out in a USP/NF dissolution apparatus No. 1 (Caleva 8ST, Ger-
many). Dry polymer matrices were accurately weighed, placed in dissolution baskets,
and immersed in 900 mL of phosphate buffer (pH 7.4) maintained at 37 °C in dissolution
vessels. At regular intervals, the pre-weighed basket-matrix system was withdrawn
from the dissolution vessel, lightly blotted with a tissue paper to remove excess test liq-
uid and reweighed. The percent water uptake, i.e., degree of swelling due to absorbed
test liquid, was estimated at each time point as the mean of three determinations (17).
Matrix erosion studies
A standard USP/NF dissolution apparatus No. 1 (Caleva 8ST, Germany) was used
for this purpose. Dry matrices were weighed, placed in dissolution baskets, and subjected
to dissolution in 500 mL of 0.05 mol L–1 phosphate buffer (pH 7.4), maintained at 37 °C,
with the basket rotating at 100 rpm. At regular intervals, basket-matrix assemblies were
removed from the dissolution vessels and dried to a constant weight in a hot air oven at
50 °C (17). The percentage matrix erosion (%E) at time t, was estimated as mean of three
determinations.
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Differential scanning calorimetery (DSC)
Thermograms of samples (P. major mucilage, propranolol hydrochloride, and pow-
dered tablet containing 1:1 of drug/mucilage) were recorded on a DSC-60 (Perkin
Elmer). Samples (3–5 mg accurately weighed to 0.01 mg) were placed in aluminum pans
and the lids were crimped using a Perkin Elmer crimper. Thermal behavior of the sam-
ples was investigated at a scanning rate of 10 oC min–1, covering a temperature range of
30–300 oC. The instrument was calibrated with an indium standard.
FT-IR spectroscopy
Fourier-transform infrared spectroscopy (FT-IR) was obtained on a Perkin Elmer
Spectrum one FT-IR system (Perkin Elmer, USA) using the KBr disk method. Samples (P.
major mucilage, propranolol hydrochloride, and powdered tablet containing 1:1 of
drug/mucilage) were mixed with KBr and compressed to 10 mm discs using a hydraulic
press at a pressure of 100 kN for 30 s. The IR scanning range was 450–4000 cm–1 and the
resolution was 2 cm–1.
Statistical analysis
ANOVA followed by Tukey’s test was used to determine significant differences be-
tween groups and p < 0.05 was considered significant.
RESULTS AND DISCUSSION
Evaluation of mucilage
The swelling factor of 1 g of P. major seeds was 14.8 ± 1.08 mL (643.5 ± 46.9 %) ac-
cording to the above method. Sharma and Koul reported 8.33 and 12.0 mL swelling fac-
tors for P. major seeds in their study (12). The yield of mucilage extraction from P. major
seeds was 22.1 % and the viscosity of its 1 % aqueous dispersion was 0.482 Pa s.
Evaluation of prepared matrices
Table I shows the composition of formulations. Mg-stearate (1 %) was added to every
formulation as lubricant. Table II compares the properties of propranolol hydrochloride ma-
trix tablets with P. major mucilage (F1-F3) and HPMC K4M and tragacanth (F4-F9). The con-
tent uniformity test showed that the drug content was between 98.71–101.09 %. The values
of hardness (from 3.91 ± 0.18, 4.32 ± 0.24, and 4.78 ± 0.23 kg cm–2 in F1, F2 and F3, re-
spectively) increased with an increase in the mucilage. This increase in F1 and F2, and
between F2 and F3, was not significant (p = 0.064 and p = 0.118, respectively), but com-
parison of F1 and F3 showed a significant increase (p = 0.005) in hardness with an in-
crease in mucilage. The tensile strength of tablets increased as the concentration of P. ma-
jor mucilage increased (from 0.44 ± 0.03, 0.51 ± 0.06, and 0.58 ± 0.06 MN m–2 in F1, F2
and F3, respectively), indicating good compactibility of mucilage powders. A significant
difference was observed between F1 and F3 (p = 0.047). Friability decreased with an in-
crease in mucilage concentration (from 1.34 ± 0.08, 1.12 ± 0.06, and 0.96 ± 0.05 % (m/m) in
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F1, F2 and F3, respectively) for tablets prepared by direct compression (p < 0.02).
Nokhodchi et al. observed the same results in propranolol hydrochloride matrix tablets
prepared with fenugreek mucilage as an excipient for controlling drug release (18).
Comparing the crushing strength of mucilage matrices with HPMC K4M matrices at
similar drug to polymer ratios revealed that the tensile strength of matrices containing
HPMC was greater than the strength of matrices containing carbohydrate polymer ex-
tracted from P. major. This comparison shows a similar crushing strength in tragacanth
containing formulations (p > 0.05). The content of HPMC did not significantly affect the
hardness, tensile strength, and friability of tablets (p > 0.05).
Drug release studies
The comparative dissolution profile (Fig. 1–3) showed that an increase in the per-
centage of P. major mucilage from 40 mg (formulation F1) to 160 mg (formulation F3) re-
sulted in a decrease in the release rate of propranolol (p < 0.001). Drug release was
slower from the HPMC K4M containing tablets compared to the mucilage containing
matrices, and drug release rates in formulations containing tragacanth were higher than
the drug release from matrices containing P. major mucilage (p < 0.001 for all investiga-
tions). Odeku and Fell reported that an increase in the percentage of Khaya gum from 60
to 90 % (m/m) mucilage containing matrices resulted in a significant decrease in the re-
lease rate of paracetamol (13). Similar results were observed in glimepiride matrix tab-
lets containing dried mucilage of Aloe barbadensis as a release retardant excipient (19).
The results show that drug release was generally linear, especially 1–3 hours after
the initial release for all formulae. Such linear drug release from hydrophilic matrices
was attributed to synchronization between swelling and erosion of the polymer in main-
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Table II. Characteristics of propranolol hydrochloride tablets prepared with different amounts of P. major









F1 3.91 ± 0.18 1.34 ± 0.08 0.44 ± 0.03 99.14 ± 3.42
F2 4.32 ± 0.24 1.12 ± 0.06 0.51 ± 0.06 101.09 ± 2.14
F3 4.78 ± 0.23 0.96 ± 0.05 0.58 ± 0.06 98.94 ± 3.17
F4 4.82 ± 0.31 0.92 ± 0.05 0.62 ± 0.07 99.34 ± 2.47
F5 5.19 ± 0.34 0.87 ± 0.07 0.67 ± 0.06 98.71 ± 3.04
F6 5.31 ± 0.34 0.75 ± 0.06 0.71 ± 0.05 100.78 ± 2.95
F7 3.11 ± 0.29 1.29 ± 0.05 0.38 ± 0.07 99.51 ± 2.16
F8 3.45 ± 0.31 1.11 ± 0.07 0.47 ± 0.05 100.67 ± 2.64
F9 3.57 ± 0.35 0.93 ± 0.05 0.52 ± 0.06 99.28 ± 2.11
a Data are shown as mean ± SD.
b n = 10; c n = 20.
taining a constant gel layer. During dissolution studies, the outer layer of tablets ap-
peared to be hydrated after being placed in the dissolution medium. There was a progre-
ssive increase in the size of this hydrated layer, followed by a gradual loss in integrity
resulting from the hydrodynamic stress induced by agitated dissolution medium (20).
Samuelsen et al. identified the composition of P. major mucilage. Seeds contained the
monosaccharides glucose, fructose, xylose and rhamnose as well as the disaccharide su-
crose and the trisaccharide planteose. Lyophilized mucilage contained about 76 % carbo-
hydrate. Only traces of proteins were detected by their method. The outer seed coat con-
tained polysaccharides that swelled in contact with water and formed a gel layer of high
viscosity (10, 21). The hydrated gel layer persisted for a considerable part of the dissolu-
tion process. This could be attributed to an increase in the viscosity of the hydrated layer
with the increase in mucilage concentration, which thus improved its resistance to ero-
sion and release.
Drug release data showed that the dissolution rate in F2 (containing 80 mg muci-
lage) was faster (p < 0.000) than F4 (containing 40 mg HPMC K4M), but the increase in
the amount of P. major mucilage in F3 (containing 160 mg mucilage) showed a slower
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Fig. 2. Comparison of the release behavior of propranolol hydrochloride from matrices containing
1:1 of drug/mucilage, HPMC K4M or tragacanth (n = 4).
Fig. 1. Comparison of the release behavior of propranolol hydrochloride from matrices containing
1:0.5 of drug/mucilage, HPMC K4M or tragacanth (n = 4).
dissolution rate in comparison with F4 (p < 0.000). Similar results were observed in ami-
nophylline matrix tablets containing Adansonia digitata mucilage. The drug release retar-
dation efficiency of the Adansonia digitata mucilage tablets at an equal polymer concen-
tration was lower than that of HPMC (22).
Dissolution rate data were analyzed based on the listed equations and the results
are given in Table III. The results show that in formulations containing P. major mucilage
as a controlling-release agent (F1-F3), release kinetics changed with an increase in the
amount of mucilage. These results show that in F1 (containing 1:0.5 drug/mucilage), the
highest correlation coefficient was achieved with the Higuchi model. The release rate
was so fast that kinetic analysis could not be fitted accurately in the Peppas model. In-
creasing the amount of P. major mucilage in F2 (containing 1:1 drug/mucilage) changed
the kinetics of release and the best fit was observed in the Peppas model. The value of n
in the Peppas model was 0.932 (> 0.89) and showed the super case II type release (16).
The results of kinetic analysis show that in F3 (containing 1:2 drug/mucilage), the high-
est correlation coefficient was achieved with the zero order model. Jani and Shah stud-
ied the mucilage of Hibiscus rosasinensis as a release retardant excipient in diclofenac so-
dium matrix tablets. Drug release kinetics from these formulations corresponded best to
zero-order kinetics (8). Nokhodchi et al. reported that drug release in propranolol hydro-
chloride matrices containing fenugreek mucilage was related to mucilage content. The
same release rate was observed in formulations containing drug/fenugreek mucilage ra-
tio 1:1 and F1 in this study. The results of release kinetics from matrices composed of
varying amounts of fenugreek mucilage showed the best fit in the Peppas model and the
release exponent (n) remained almost unchanged whereas in formulations containing P.
major mucilage, the release kinetic changed with an increase in mucilage amount (18).
Ford et al. proved that the sum of squares of errors involves values that can be used
to determine the most appropriate model for a data set. The sum of squares of errors is a
measure of discrepancies between the observed data and the values that would have been
predicted by a particular model (23). In formulations containing HPMC K4M (F4-F6),
the highest correlation coefficients were achieved with Peppas, Higuchi, and first order
models, respectively. The lowest sums of squares of errors were observed in the Peppas
model in F4-F6 containing HPMC K4M. The values of n in the Peppas model in F4-F6
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Fig. 3. Comparison of the release behavior of propranolol hydrochloride from matrices containing
1:2 of drug/mucilage, HPMC K4M or tragacanth (n = 4).
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were 0.542, 0.675, and 0.705, respectively. These values indicated that release mecha-
nisms were similar and were based on anomalous transport of the drug from the matrix.
Similar values of n of around 0.6 were found for propranolol hydrochloride release from
hydroxypropyl methylcellulose K4M matrices (24). Kinetic analysis of drugs released
from matrices containing tragacanth (F7-F9) showed the best fit with the Higuchi model.
Rasul et al. evaluated the kinetics of metoprolol release from matrices containing
tragacanth. The results show that the best fit was observed in the Higuchi model (25).
Swelling and erosion behavior of matrix tablets
Swelling and erosion studies were carried out on all formulations. The results of these
tests in phosphate buffer (pH 7.4) are provided as the percentage weight change and the
percentage remaining of tablet mass, as shown in Figs. 4 and 5. The swelling behavior
indicated the rate at which this formulation absorbed water from dissolution media and
swelled. The changes in weight, characteristic of water uptake and swelling, started
from the beginning and continued until 300 min of experiment, with the exception of F1
and F2 which disintegrated after 3 and 4 hours, respectively. Matrices containing a lower
proportion of mucilage showed a lower degree of mass gain with time (p < 0.000). The
percent swelling of formulations containing HPMC K4M was found to be higher than
that of formulations containing P. major mucilage (p < 0.000). Formulations containing
tragacanth showed the lowest swelling in comparison with other formulations (p < 0.01).
Matrix erosion measured the mass loss from matrix tablets immersed in dissolution
media as a function of time. The remaining percentage of matrices is shown in Fig. 5 and
reflects the amount of polymer dissolved and erosion of the matrix during the dissolu-
tion process. Mass loss from the tablets increased progressively with the erosion. The ex-
tent of erosion in formulations containing P. major mucilage (F1-F3) was higher than for
HPMC matrices (F4-F6) and lower than for tablets containing tragacanth (p < 0.001).
There was a significant (p < 0.000) increase in the remaining percent of the tablet with in-
creased P. major mucilage concentrations (formulations F1-F3). These erosion profiles
confirm the release pattern of propranolol hydrochloride from the P. major mucilage con-
taining matrix tablets. Singh et al. studied the Mimosa pudica seed mucilage as a sustained
release excipient in diclofenac sodium matrix tablets. The swelling and erosion studies
revealed that as the proportion of mucilage in tablets was increased, there was a corre-
sponding increase in percent swelling and decrease in percent erosion of tablets (26).
There was an initial rapid uptake of water by dry matrices during the first 0.5–1 h,
followed by a leveling off of wet weights due to the increasing rate of erosional release.
This proceeded until the rate of erosion exceeded the rate of water uptake, with a resul-
tant decrease in weight with time. Similar results were observed in the xanthan gum
containing tablets (27).
Interaction between drug and mucilage
It has been shown that polymorphic changes of the drug are important factors that
may affect the dissolution rate and bioavailability. On the other hand, the importance of
polymorphism for the therapeutic effectiveness of a drug and the pharmaceutical impli-
cation of the presence of metastable crystalline forms in the bulk powder are well
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known. It has also been shown that the crystal structure could affect tablet porosity and
density, the mechanism of disintegration and aggregation, as well as the plastic and elas-
tic properties of solid dosage forms (28). It is therefore important to study polymorphic
changes of propranolol hydrochloride in matrix tablets containing P. major mucilage as a
release retardant excipient. Bartolomei et al. reported that (R, S) propranolol hydrochlo-
ride existed in two crystalline forms, designated I and II (28).
The results of DSC thermograms are shown in Fig. 6. The P. major mucilage ther-
mogram exhibits a very broad endothermic peak at 95.2 °C, which is associated with loss
of water from the carbohydrate polymer. Further, an exothermic transition was recorded
above 223.7 °C, which is indicative of mucilage degradation. The DSC profiles of forms I
and II, recorded at a heating rate of 10 °C min–1, showed rather sharp fusion endotherms:
form I with an onset temperature of 163.0 ± 0.2 °C (peak temperature: 166 ± 0.5 °C), while
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Fig. 5. The remaining percentage of different formulations of propranolol hydrochloride matrices
containing P. major mucilage or HPMC K4M and tragacanth (n = 3).
Fig. 4. The percentage of swelling (weight change) of different formulations of propranolol hydro-
chloride matrices containing P. major mucilage or HPMC K4M and tragacanth (n = 3).
form II showed an onset temperature of 161.8 ± 0.1 °C (peak temperature: 163.6 ± 0.2 °C).
According to Fig. 6, propranolol hydrochloride showed an endothermic peak around its
melting point (164.2 ± 0.1 °C). The matrix tablet containing the drug/mucilage ratio 1:1
showed the same peak in this area, which indicates that there was no interaction between
the drug and P. major mucilage during the formulation process. From the above finding
it can be concluded that the delayed dissolution rate of propranolol hydrochloride was
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Fig. 6. Differential scanning calorimetry of P. major mucilage, propranolol hydrochloride, and ma-
trix tablet containing 1:1 of drug/mucilage ratio.
Fig. 7. FTIR spectra of P. major mucilage, propranolol hydrochloride, and matrix tablet containing
1:1 of drug/mucilage ratio.
not due to the formation of a complex between the drug and P. major mucilage or
changes in drug crystallinity.
FT-IR spectral studies (Fig. 7) confirmed the above conclusion. In case of pure P. ma-
jor mucilage, a broad band appearing around 3437.5 cm–1 corresponds to OH stretching,
wave number 1742.9 cm–1 depicts the stretching zone of C=O, and 1040.1 cm–1 depicts
the stretching vibration of the C-O group, which is characteristic of polysaccharides (3).
The FT-IR spectrum of propranolol hydrochloride revealed the presence of peaks at
2964.9 cm–1 due to the presence of a secondary amine group, peaks at 3280.6 cm–1 due to
the hydroxyl group (secondary), the aryl alkyl ether displayed a stretching band at
1267.8 cm–1 and the peak at 979.9 cm–1 was due to a-substituted naphthalene. In the
spectra of the mucilage and drug blend, major characteristic peaks of both propranolol
hydrochloride individually and P. major mucilage were retained. This confirms that
there were no physical or chemical interactions amongst the components of the formula-
tion and compatibility of the drug with the natural carbohydrate polymer.
CONCLUSIONS
This study has demonstrated the potential of P. major mucilage to act as a release re-
tardant excipient in matrix formulations. An increase in the concentration of mucilage in
binary drug-mucilage mixtures resulted in an increase in the crushing strength of tab-
lets. Release kinetics showed that the mechanism was related to the mucilage content
and at a concentration of about 66 % (m/m) the best fitting was observed in the zero-or-
der model. The present study has demonstrated that P. major mucilage has great poten-
tial for being used as a controlled release excipient.
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